SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-14-007383
Filing Date
2014-02-10
Accepted
2014-02-10 18:48:52
Documents
1
Period of Report
2014-02-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v367357_4.html 4  
1 OWNERSHIP DOCUMENT v367357_4.xml 4 5749
  Complete submission text file 0001144204-14-007383.txt   7117
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Issuer) CIK: 0001235007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ENDOCYTE, INC. 3000 KENT AVENUE, SUITE A1-100 WEST LAFAYETTE IN 47906
Business Address
Brinkley Michael A. (Reporting) CIK: 0001579573 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35050 | Film No.: 14590801